These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26123643)

  • 1. Synthesis and biological evaluation of novel myrtucommulones and structural analogues that target mPGES-1 and 5-lipoxygenase.
    Wiechmann K; Müller H; Huch V; Hartmann D; Werz O; Jauch J
    Eur J Med Chem; 2015 Aug; 101():133-49. PubMed ID: 26123643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1.
    Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O
    Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
    Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
    Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.
    Hieke M; Greiner C; Thieme TM; Schubert-Zsilavecz M; Werz O; Zettl H
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1329-33. PubMed ID: 21310608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes.
    Filosa R; Peduto A; Schaible AM; Krauth V; Weinigel C; Barz D; Petronzi C; Bruno F; Roviezzo F; Spaziano G; D'Agostino B; De Rosa M; Werz O
    Eur J Med Chem; 2015 Apr; 94():132-9. PubMed ID: 25765759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
    Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors.
    Chini MG; De Simone R; Bruno I; Riccio R; Dehm F; Weinigel C; Barz D; Werz O; Bifulco G
    Eur J Med Chem; 2012 Aug; 54():311-23. PubMed ID: 22683242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.
    Hieke M; Greiner C; Dittrich M; Reisen F; Schneider G; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2011 Jul; 54(13):4490-507. PubMed ID: 21591611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
    De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
    J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibition.
    Hanke T; Lamers C; Gomez RC; Schneider G; Werz O; Schubert-Zsilavecz M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3757-63. PubMed ID: 25037914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Munronia pinnata (Wall.) Theob.: unveiling phytochemistry and dual inhibition of 5-lipoxygenase and microsomal prostaglandin E2 synthase (mPGES)-1.
    Napagoda M; Gerstmeier J; Koeberle A; Wesely S; Popella S; Lorenz S; Scheubert K; Böcker S; Svatoš A; Werz O
    J Ethnopharmacol; 2014 Feb; 151(2):882-90. PubMed ID: 24315851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX.
    Elkady M; Nieß R; Schaible AM; Bauer J; Luderer S; Ambrosi G; Werz O; Laufer SA
    J Med Chem; 2012 Oct; 55(20):8958-62. PubMed ID: 22992107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX).
    Liedtke AJ; Keck PR; Lehmann F; Koeberle A; Werz O; Laufer SA
    J Med Chem; 2009 Aug; 52(15):4968-72. PubMed ID: 19719242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones.
    Svouraki A; Garscha U; Kouloura E; Pace S; Pergola C; Krauth V; Rossi A; Sautebin L; Halabalaki M; Werz O; Gaboriaud-Kolar N; Skaltsounis AL
    J Nat Prod; 2017 Mar; 80(3):699-706. PubMed ID: 28240894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1.
    Hanke T; Rörsch F; Thieme TM; Ferreiros N; Schneider G; Geisslinger G; Proschak E; Grösch S; Schubert-Zsilavecz M
    Bioorg Med Chem; 2013 Dec; 21(24):7874-83. PubMed ID: 24183739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy.
    Gürses T; Olğaç A; Garscha U; Gür Maz T; Bal NB; Uludağ O; Çalışkan B; Schubert US; Werz O; Banoglu E
    Bioorg Chem; 2021 Jul; 112():104861. PubMed ID: 33826984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzo[d]isothiazole 1,1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1.
    Shang E; Wu Y; Liu P; Liu Y; Zhu W; Deng X; He C; He S; Li C; Lai L
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2764-7. PubMed ID: 24794107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1.
    De Simone R; Bruno I; Riccio R; Stadler K; Bauer J; Schaible AM; Laufer S; Werz O
    Bioorg Med Chem; 2012 Aug; 20(16):5012-6. PubMed ID: 22795900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
    Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R
    Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Pollastro F; Northoff H; Werz O
    Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.